XORTX Therapeutics Announces US$1.1 Million Registered Direct Offering
I'm PortAI, I can summarize articles.
XORTX Therapeutics Inc. has announced a US$1.1 million registered direct offering, selling 1,746,631 common shares at US$0.63 each to an institutional investor. D. Boral Capital LLC is the sole placement agent. The net proceeds will be used for working capital and general corporate purposes, with the offering expected to close pending customary conditions and regulatory approval.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments